Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1504 (LINC01504) is a human non-protein-coding RNA gene classified as a long non-coding RNA (lncRNA)[1]. There is no evidence in the current biomedical literature to support its function as a canonical therapeutic target, such as a receptor, enzyme, transporter, or disease marker. Its function, disease associations, interacting drugs, clinical biomarker potential, and safety profile are currently uncharacterized. The molecule is part of the broad lncRNA class, which are RNA transcripts longer than 200 nucleotides that do not encode proteins and are often involved in complex gene regulatory networks and chromatin remodeling, but no specific biological or pathological roles have been attributed to LINC01504 in curated or experimental resources as of this time. Because of the lack of functionally validated or disease-relevant information, LINC01504 is not considered a druggable or therapeutic target[1]. Additional details: - No substantial entries, aliases, or alternative names are reported beyond the standardized gene symbol and gene name[1]. - No Gene Ontology data, known pathways, disease roles, or experimental functional information are available for LINC01504[1]. - If you are seeking information on a similarly named but different lncRNA such as LINC00504 or LINC00324, which do have reported biological and cancer-related activities[2][3], this entry is not the same—please verify the gene symbol. If you require data on another well-studied lncRNA or have a potential misspelling, please clarify—the provided information and search context do not identify LINC01504 as a functional or therapeutic target gene in human biology or medicine.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1504 (LINC01504).